Con:Raisescost forconsumersID&E:RegulatoryoversightprotectsfairnessPro:Drivesinnovation✅Pro:Encouragesefficiency“Innovation”Con:ReducescompetitionEdwardsLifesciences“CaseStudyMentioned”Pro:Encouragesefficiency✅Pro:Expandstreatmentoptions“Innovation”Pro:Lowerslong-termcostsPro:ExpandstreatmentoptionsPro:Createscompetitiveadvantage❌Con: Canlimitinnovation (ifmonopolized)✅Pro:Lowerslong-termcosts🌎ID&E:Impactsaffordability forunderservedpopulations“Antitrust”❌Con:Potential jobloss insmaller firms✅Pro:DrivesinnovationThoratecJenaValve❌Con:Raisescost forconsumers❌Con:Stiflessmallercompetitors🌎ID&E:RegulatoryoversightprotectsfairnessID&E: Riskof bias intechnologyadoption✅Pro:Improvespatientoutcomes🌎ID&E:May reduceequitableaccess ifcosts rise❌Con:Reducescompetition✅Pro:CreatescompetitiveadvantageID&E:ImpactsaffordabilityforunderservedpopulationsID&E:Increasesaccess tolife-savingdevicesCon: Riskof marketmonopolyHeartWareTAVR-ARdevice🌎ID&E:Increasesaccess tolife-savingdevices🌎ID&E:Risk of biasintechnologyadoption🌎ID&E:Could createglobaldisparitiesCon:Potential jobloss insmaller firms✅Pro:PromotesfasterdevelopmentID&E:Opportunityto designfor inclusion🌎ID&E:Opportunityto designfor inclusion❌Con:Risk ofmarketmonopolyCon:AntitrustchallengesCon: StiflessmallercompetitorsCon: Canlimitinnovation (ifmonopolized)ID&E: Couldcreateglobaldisparities“Antitrust”❌Con:AntitrustchallengesID&E: Mayreduceequitableaccess ifcosts rise“CaseStudyMentioned”Pro:ImprovespatientoutcomesPro:PromotesfasterdevelopmentCon:Raisescost forconsumersID&E:RegulatoryoversightprotectsfairnessPro:Drivesinnovation✅Pro:Encouragesefficiency“Innovation”Con:ReducescompetitionEdwardsLifesciences“CaseStudyMentioned”Pro:Encouragesefficiency✅Pro:Expandstreatmentoptions“Innovation”Pro:Lowerslong-termcostsPro:ExpandstreatmentoptionsPro:Createscompetitiveadvantage❌Con: Canlimitinnovation (ifmonopolized)✅Pro:Lowerslong-termcosts🌎ID&E:Impactsaffordability forunderservedpopulations“Antitrust”❌Con:Potential jobloss insmaller firms✅Pro:DrivesinnovationThoratecJenaValve❌Con:Raisescost forconsumers❌Con:Stiflessmallercompetitors🌎ID&E:RegulatoryoversightprotectsfairnessID&E: Riskof bias intechnologyadoption✅Pro:Improvespatientoutcomes🌎ID&E:May reduceequitableaccess ifcosts rise❌Con:Reducescompetition✅Pro:CreatescompetitiveadvantageID&E:ImpactsaffordabilityforunderservedpopulationsID&E:Increasesaccess tolife-savingdevicesCon: Riskof marketmonopolyHeartWareTAVR-ARdevice🌎ID&E:Increasesaccess tolife-savingdevices🌎ID&E:Risk of biasintechnologyadoption🌎ID&E:Could createglobaldisparitiesCon:Potential jobloss insmaller firms✅Pro:PromotesfasterdevelopmentID&E:Opportunityto designfor inclusion🌎ID&E:Opportunityto designfor inclusion❌Con:Risk ofmarketmonopolyCon:AntitrustchallengesCon: StiflessmallercompetitorsCon: Canlimitinnovation (ifmonopolized)ID&E: Couldcreateglobaldisparities“Antitrust”❌Con:AntitrustchallengesID&E: Mayreduceequitableaccess ifcosts rise“CaseStudyMentioned”Pro:ImprovespatientoutcomesPro:Promotesfasterdevelopment

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. Con: Raises cost for consumers
  2. ID&E: Regulatory oversight protects fairness
  3. Pro: Drives innovation
  4. ✅Pro: Encourages efficiency
  5. “Innovation”
  6. Con: Reduces competition
  7. Edwards Lifesciences
  8. “Case Study Mentioned”
  9. Pro: Encourages efficiency
  10. ✅Pro: Expands treatment options
  11. “Innovation”
  12. Pro: Lowers long-term costs
  13. Pro: Expands treatment options
  14. Pro: Creates competitive advantage
  15. ❌Con: Can limit innovation (if monopolized)
  16. ✅Pro: Lowers long-term costs
  17. 🌎ID&E:Impacts affordability for underserved populations
  18. “Antitrust”
  19. ❌Con: Potential job loss in smaller firms
  20. ✅Pro: Drives innovation
  21. Thoratec
  22. JenaValve
  23. ❌Con: Raises cost for consumers
  24. ❌Con: Stifles smaller competitors
  25. 🌎ID&E: Regulatory oversight protects fairness
  26. ID&E: Risk of bias in technology adoption
  27. ✅Pro: Improves patient outcomes
  28. 🌎ID&E: May reduce equitable access if costs rise
  29. ❌Con: Reduces competition
  30. ✅Pro: Creates competitive advantage
  31. ID&E:Impacts affordability for underserved populations
  32. ID&E: Increases access to life-saving devices
  33. Con: Risk of market monopoly
  34. HeartWare
  35. TAVR-AR device
  36. 🌎ID&E: Increases access to life-saving devices
  37. 🌎ID&E: Risk of bias in technology adoption
  38. 🌎ID&E: Could create global disparities
  39. Con: Potential job loss in smaller firms
  40. ✅Pro: Promotes faster development
  41. ID&E: Opportunity to design for inclusion
  42. 🌎ID&E: Opportunity to design for inclusion
  43. ❌Con: Risk of market monopoly
  44. Con: Antitrust challenges
  45. Con: Stifles smaller competitors
  46. Con: Can limit innovation (if monopolized)
  47. ID&E: Could create global disparities
  48. “Antitrust”
  49. ❌Con: Antitrust challenges
  50. ID&E: May reduce equitable access if costs rise
  51. “Case Study Mentioned”
  52. Pro: Improves patient outcomes
  53. Pro: Promotes faster development